These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11167780)

  • 1. Bone resorption is increased in young adults with thalassaemia major.
    Voskaridou E; Kyrtsonis MC; Terpos E; Skordili M; Theodoropoulos I; Bergele A; Diamanti E; Kalovidouris A; Loutradi A; Loukopoulos D
    Br J Haematol; 2001 Jan; 112(1):36-41. PubMed ID: 11167780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical markers of bone turnover and bone mineral density in patients with beta-thalassaemia major.
    Eren E; Yilmaz N
    Int J Clin Pract; 2005 Jan; 59(1):46-51. PubMed ID: 15707464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of bone mineral density of the lumbar spine in patients with beta-thalassemia major with dual-energy x-ray absorptiometry and quantitative computed tomography: a comparison study.
    Angelopoulos NG; Katounda E; Rombopoulos G; Goula A; Kaltzidou V; Kaltsas D; Ioannis P; Tolis G
    J Pediatr Hematol Oncol; 2006 Feb; 28(2):73-8. PubMed ID: 16462577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism.
    Minisola S; Pacitti MT; Rosso R; Pellegrino C; Ombricolo E; Pisani D; Romagnoli E; Damiani C; Aliberti G; Scarda A; Mazzuoli SF
    J Endocrinol Invest; 1997 Oct; 20(9):559-65. PubMed ID: 9413811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia.
    Voskaridou E; Terpos E; Spina G; Palermos J; Rahemtulla A; Loutradi A; Loukopoulos D
    Br J Haematol; 2003 Nov; 123(4):730-7. PubMed ID: 14616979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral metabolism in adults with beta-thalassaemia major and intermedia.
    Dresner Pollack R; Rachmilewitz E; Blumenfeld A; Idelson M; Goldfarb AW
    Br J Haematol; 2000 Dec; 111(3):902-7. PubMed ID: 11122154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
    Kemink SA; Hermus AR; Swinkels LM; Lutterman JA; Smals AG
    J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF; Geyikli I; Yazgan P; Celik A
    Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
    Biermasz NR; Hamdy NA; Janssen YJ; Roelfsema F
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment for osteoporosis in people with ß-thalassaemia.
    Bhardwaj A; Swe KM; Sinha NK; Osunkwo I
    Cochrane Database Syst Rev; 2016 Mar; 3():CD010429. PubMed ID: 26964506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone density and metabolism in thalassaemia.
    Lala R; Chiabotto P; Di Stefano M; Isaia GC; Garofalo F; Piga A
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():785-90. PubMed ID: 10091147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone remodeling and bone mineral density during pregnancy.
    Ulrich U; Miller PB; Eyre DR; Chesnut CH; Schlebusch H; Soules MR
    Arch Gynecol Obstet; 2003 Oct; 268(4):309-16. PubMed ID: 14504876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine and bone disease in appropriately treated adult patients with beta-thalassemia major.
    Baldini M; Forti S; Marcon A; Ulivieri FM; Orsatti A; Tampieri B; Airaghi L; Zanaboni L; Cappellini MD
    Ann Hematol; 2010 Dec; 89(12):1207-13. PubMed ID: 20582415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study.
    Forni GL; Perrotta S; Giusti A; Quarta G; Pitrolo L; Cappellini MD; D'Ascola DG; Borgna Pignatti C; Rigano P; Filosa A; Iolascon G; Nobili B; Baldini M; Rosa A; Pinto V; Palummeri E
    Br J Haematol; 2012 Jul; 158(2):274-282. PubMed ID: 22571408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function.
    Bolanowski M; Daroszewski J; Medraś M; Zadrozna-Sliwka B
    J Bone Miner Metab; 2006; 24(1):72-8. PubMed ID: 16369902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone biomarkers as tools in osteoporosis management.
    Eyre DR
    Spine (Phila Pa 1976); 1997 Dec; 22(24 Suppl):17S-24S. PubMed ID: 9431640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women.
    Chaki O; Yoshikata I; Kikuchi R; Nakayama M; Uchiyama Y; Hirahara F; Gorai I
    J Bone Miner Res; 2000 Aug; 15(8):1537-44. PubMed ID: 10934652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mineral density, body composition and bone turnover in patients with congenital hypogonadotropic hypogonadism.
    Laitinen EM; Hero M; Vaaralahti K; Tommiska J; Raivio T
    Int J Androl; 2012 Aug; 35(4):534-40. PubMed ID: 22248317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical markers as predictors of rates of bone loss after menopause.
    Rogers A; Hannon RA; Eastell R
    J Bone Miner Res; 2000 Jul; 15(7):1398-404. PubMed ID: 10893690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.